Frank J. McCaney serves as a senior business advisor to D3D and is helping D3D secure FDA approval. Mr. McCaney is President and CEO of Strata Skin Sciences, Inc. (SSKN:NASDAQ). From 2013 to 2016 he served as CEO of Corpak MedSystems, a private equity backed enterprise, until it was sold to Halyard Health. Previous to Corpak Mr. McCaney was the founder and CEO of Nitric BioTherapeutics, a drug delivery start-up. He was also involved in the spin-out of VIASYS Healthcare Inc. (VAS:NYSE) from Thermo Electron. VIASYS was sold to Cardinal Health in 2007. Mr. McCaney is a Biochemist by training and has worked in the medical device industry for more than 30 years from R&D and Sales to positions of increasing responsibility. He also serves on the Board of Diasome Pharmaceuticals.